Simultaneously, S. Murakami et al. reported that SRY promotes the proliferation, invasion, and tumorigenicity of two male mice HCC cell lines by directly activating Sgf29 partly through histone H3 acetylation [25]. Here, SRY is linked to hepatocellular carcinoma.